RVMDW vs. BW

Last updated Aug 1, 2026

RVMDW (Revolution Medicines Inc. Warrant) and BW (Babcock & Wilcox Enterprises, Inc.) are both stocks. RVMDW operates in Biotechnology (Healthcare), while BW operates in Specialty Industrial Machinery (Industrials). Over the past year, RVMDW returned 3885.42% vs 925.04% for BW. Their 0.03 correlation means their historical movements had little consistent relationship.

Performance

RVMDW vs. BW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revolution Medicines Inc. Warrant (RVMDW) and Babcock & Wilcox Enterprises, Inc. (BW). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RVMDW achieves a 917.66% return, which is significantly higher than BW's 50.81% return.

RVMDW

• 1D: -3.19%
• 1M: 0.16%
• 6M: 517.10%
• YTD: 917.66%
• 1Y: 3,885.42%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 130.63%

BW

• 1D: -1.58%
• 1M: -20.61%
• 6M: -0.81%
• YTD: 50.81%
• 1Y: 925.04%
• 3Y*: 20.98%
• 5Y*: 5.96%
• 10Y*: -24.05%
• ALL TIME*: -23.82%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
BW Babcock & Wilcox Enterprises, Inc.	$29.60M	$37.10M	$59.24M
RVMDW Revolution Medicines Inc. Warrant	$144.01K	$204.24K	$421.34K

RVMDW vs. BW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
RVMDW Revolution Medicines Inc. Warrant	917.66%	422.17%	-45.45%	-67.00%
BW Babcock & Wilcox Enterprises, Inc.	50.81%	286.59%	12.33%	-4.58%

Correlation

The correlation between RVMDW and BW is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.02
Correlation (All Time) Calculated using the full available price history since Nov 17, 2023	0.03

Fundamentals

Market Cap RVMDW : $41.48B BW : $1.07B
EPS RVMDW : -$7.13 BW : -$0.79
Total Revenue (TTM) RVMDW : $0.00 BW : $668.48M
Gross Profit (TTM) RVMDW : -$4.70M BW : $121.68M
EBITDA (TTM) RVMDW : -$1.34B BW : -$41.40M

Return for Risk

RVMDW vs. BW — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

RVMDW

RVMDW Risk / Return Rank: 100
RVMDW Sharpe Ratio Rank: 100
RVMDW Sortino Ratio Rank: 99
RVMDW Omega Ratio Rank: 99
RVMDW Calmar Ratio Rank: 100
RVMDW Martin Ratio Rank: 100

BW

BW Risk / Return Rank: 99
BW Sharpe Ratio Rank: 100
BW Sortino Ratio Rank: 98
BW Omega Ratio Rank: 96
BW Calmar Ratio Rank: 99
BW Martin Ratio Rank: 99

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

RVMDW vs. BW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines Inc. Warrant (RVMDW) and Babcock & Wilcox Enterprises, Inc. (BW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RVMDW	BW	Difference
Sharpe ratio: Return per unit of total volatility	19.12	6.89	+12.23
Sortino ratio: Return per unit of downside risk	6.70	4.48	+2.21
Omega ratio: Gain probability vs. loss probability	1.87	1.53	+0.34
Calmar ratio: Return relative to maximum drawdown	74.87	14.26	+60.61
Martin ratio: Return relative to average drawdown	171.25	44.23	+127.02

RVMDW vs. BW - Sharpe Ratio Comparison

The current RVMDW Sharpe Ratio is 19.12, which is higher than the BW Sharpe Ratio of 6.89. The chart below compares the historical Sharpe Ratios of RVMDW and BW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RVMDW vs. BW - Drawdown Comparison

The maximum RVMDW drawdown since its inception was -96.90%, roughly equal to the maximum BW drawdown of -99.89%. Use the drawdown chart below to compare losses from any high point for RVMDW and BW.

Drawdown Indicators

	RVMDW	BW	Difference
Max Drawdown Largest peak-to-trough decline	-96.90%	-99.89%	+2.99%
Max Drawdown (1Y) Largest decline over 1 year	-59.65%	-62.72%	+3.07%
Max Drawdown (3Y) Largest decline over 3 years	—	-95.33%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-97.39%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.85%	—
Current Drawdown Current decline from peak	-3.58%	-95.96%	+92.38%
Average Drawdown Average peak-to-trough decline	-63.64%	-82.94%	+19.30%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.03%	20.18%	+5.85%

Volatility

RVMDW vs. BW - Volatility Comparison

The current volatility for Revolution Medicines Inc. Warrant (RVMDW) is 24.71%, while Babcock & Wilcox Enterprises, Inc. (BW) has a volatility of 31.34%. This indicates that RVMDW experiences smaller price fluctuations and is considered to be less risky than BW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RVMDW	BW	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.71%	31.34%	-6.63%
Volatility (6M) Calculated over the trailing 6-month period	113.04%	88.95%	+24.09%
Volatility (1Y) Calculated over the trailing 1-year period	233.69%	130.11%	+103.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	305.49%	111.10%	+194.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	305.49%	108.62%	+196.87%

Dividends

RVMDW vs. BW - Dividend Comparison

RVMDW has not paid dividends to shareholders, while BW's dividend yield for the trailing twelve months is around 4.36%.

Position	TTM
BW Babcock & Wilcox Enterprises, Inc.	4.36%
RVMDW Revolution Medicines Inc. Warrant	0.00%

Financials

Frequently Asked Questions

Can I hold both RVMDW and BW in my portfolio?

RVMDW and BW have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RVMDW or BW?

BW has higher volatility (31.34%) compared to RVMDW (24.71%). In terms of maximum drawdown, RVMDW dropped -96.90% vs BW's -99.89%.

Which has better risk-adjusted returns?

RVMDW currently has the higher Sharpe Ratio (19.12 vs 6.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.